CYP24A1 and neoplasm: Accordingly, the expression of VDR, CYP27B1, and CYP24A1 in breast cancer may favor tumor progression by decreasing the presence of the active 1,25(OH)2D. Nonetheless, it is not known at what concentrations 25(OH)D is protective against breast cancer.